SarcoNet: A Pilot Study on Integrating Clinical and Kinematic Features for Sarcopenia Classification

<b>Background and Objectives:</b> Sarcopenia is a progressive loss of skeletal muscle mass and function in elderly adults, posing a significant risk of frailty, falls, and morbidity. The current study designs and evaluates SarcoNet, a novel artificial neural network (ANN)-based classification framework developed in order to classify Sarcopenic from non-Sarcopenic subjects using a comprehensive real-time dataset. <b>Methods:</b> This pilot study involved 30 subjects, who were divided into Sarcopenic and non-Sarcopenic groups based on physician assessment. The collected dataset consists of thirty-one clinical parameters like skeletal muscle mass, which is collected using various equipment such as Body Composition Analyser, along with ten kinetic features which are derived from video-based gait analysis of joint angles obtained during walking on three terrain types such as slope, steps, and parallel path. The performance of the designed ANN-based SarcoNet was benchmarked against the traditional machine learning classifiers utilised including Support Vector Machine (SVM), k-Nearest Neighbours (k-NN), and Random Forest (RF), as well as hard and soft voting ensemble classifiers. <b>Results:</b> SarcoNet achieved the highest overall classification accuracy of about 94%, with a specificity and precision of about 100%, an F1-score of about 92.4%, and an AUC of 0.94, outperforming all other models. The incorporation of lower-limb joint kinetics such as knee flexion, extension, ankle plantarflexion and dorsiflexion significantly enhanced predictive capability of the model and thus reflecting the functional deterioration characteristic of muscles in Sarcopenia. <b>Conclusions:</b> SarcoNet provides a promising AI-driven solution in Sarcopenia diagnosis, especially in low-resource healthcare settings. Future work will focus on improving the dataset, validating the model across diverse populations, and incorporating explainable AI to improve clinical adoption.